ImmunoGen, Inc. - Market Overview 2014

1. ImmunoGen, Inc. - Product Pipeline Review-2014 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: January 2014 Single User PDF: US$ 1500 Corporate User PDF: US$ 4500 © ReportsnReports.com / Contact sales@reportsandreports.com

2. ImmunoGen, Inc. - Product Pipeline Review-2014 Researcher’s pharmaceuticals report, "ImmunoGen, Inc. Product Pipeline Review 2014" provides data on the ImmunoGen, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Researcher’ proprietary databases, ImmunoGen, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from ImmunoGen, Inc. and industry-specific third party sources, put together by Researcher’s team. Inquiry Before Buying on this Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=274882 . Scope ImmunoGen, Inc. Brief ImmunoGen, Inc. overview including business description, key information and facts, and its locations and subsidiaries. Review of current pipeline of ImmunoGen, Inc. human therapeutic division. Overview of pipeline therapeutics across various therapy areas. Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

3. ImmunoGen, Inc. - Product Pipeline Review-2014 Product profiles for late stage and clinical stage products of ImmunoGen, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. Recent updates of the ImmunoGen, Inc.'s pipeline in the last quarter. Key discontinued and dormant projects. Latest news and deals relating to the products. Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=274882 Reasons to buy Evaluate ImmunoGen, Inc.'s strategic position with total access to detailed information on its product pipeline. Assess the growth potential of ImmunoGen, Inc. in its therapy areas of focus. Identify new drug targets and therapeutic classes in the ImmunoGen, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. Exploit collaboration and partnership opportunities with ImmunoGen, Inc.. opportunities in those areas. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

4. ImmunoGen, Inc. - Product Pipeline Review-2014 Table of Contents Table of Contents 2List of Tables 4List of Figures 4ImmunoGen, Inc. Snapshot 5ImmunoGen, Inc. Overview 5Key Information 5Key Facts 5ImmunoGen, Inc. - Research and Development Overview 6Key Therapeutic Areas 6ImmunoGen, Inc. - Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products - Monotherapy 10Pipeline Products - Partnered Products 11Partnered Products/Combination Treatment Modalities 12Pipeline Products - Out-Licensed Products 13Out-Licensed Products/Combination Treatment Modalities 14 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

5. ImmunoGen, Inc. - Product Pipeline Review-2014 List of Tables ImmunoGen, Inc., Key Information 5ImmunoGen, Inc., Key Facts 5ImmunoGen, Inc. - Pipeline by Indication, 2014 8ImmunoGen, Inc. - Pipeline by Stage of Development, 2014 9ImmunoGen, Inc. - Monotherapy Products in Pipeline, 2014 10ImmunoGen, Inc. - Partnered Products in Pipeline, 2014 11ImmunoGen, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12ImmunoGen, Inc. - Out-Licensed Products in Pipeline, 2014 13ImmunoGen, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14ImmunoGen, Inc. - Phase I, 2014 15ImmunoGen, Inc. - Preclinical, 2014 16ImmunoGen, Inc. - Discovery, 2014 17ImmunoGen, Inc. - Pipeline by Therapeutic Class, 2014 26ImmunoGen, Inc. - Pipeline by Target, 2014 27ImmunoGen, Inc. - Pipeline by Route of Administration, 2014 28ImmunoGen, Inc. - Pipeline by Molecule Type, 2014 29 Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “ImmunoGen, Inc. - Product Pipeline Review - 2014” report OR for any other market research and intelligence needs you may have for your business. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com